医学
急性呼吸窘迫综合征
细胞外基质
纤维化
间充质干细胞
特发性肺纤维化
肺纤维化
治疗方法
人口
炎症
生物信息学
后遗症
基质金属蛋白酶
磁共振成像
重症监护医学
肌成纤维细胞
疾病
病理
生物标志物
免疫系统
干细胞
免疫学
细胞疗法
肺
肺炎
病态的
成纤维细胞
急性呼吸窘迫
作者
Guiyang Jia,Zhikun Gan,Enhua Feng,Zhiyou Zheng,Erqin Song,Mingjiang Qian,Miao Chen,Guoyue Liu
标识
DOI:10.1017/erm.2026.10077
摘要
BACKGROUND: Acute respiratory distress syndrome (ARDS) is a severe inflammatory lung injury caused by various factors, including infection, trauma and shock. The predominant pathological alteration in its late stages is pulmonary fibrosis (PF), characterised by progressive extracellular matrix deposition, architectural destruction and functional impairment. Particularly in COVID-19-induced ARDS, PF incidence has markedly increased, making it a major sequela impacting patients' long-term quality of life. METHODS: This review systematically examines post-acute lung injury (ALI)/ARDS PF through three perspectives: pathogenesis, prediction and treatment. RESULTS: Mechanistically, the fibrotic process involves epithelial injury and mesenchymal transition, fibroblast activation with aberrant extracellular matrix remodelling, dysregulated inflammation with immune cell involvement and clinical management-related factors. For prediction, various biomarkers (including growth factors, matrix proteins and inflammatory markers) and imaging features (particularly high-resolution computed tomography (HRCT) and magnetic resonance imaging (MRI) characteristics) demonstrate clinical value. Integrated multiparameter models incorporating artificial intelligence show promise for early identification and risk stratification of high-risk patients. Therapeutic strategies encompass anti-inflammatory approaches (e.g., corticosteroids and antioxidants), antifibrotic agents (pirfenidone and nintedanib), cell-based therapies (mesenchymal stem cells and exosomes) and emerging genetic/RNA interventions. However, specific preventive and therapeutic approaches tailored to the post-ALI/ARDS PF population remain inadequate in clinical practice. CONCLUSIONS: Future research should focus on elucidating underlying mechanisms, refining early-warning systems, exploring personalised treatments and facilitating clinical translation. The ultimate goal is to transition from traditional supportive care to proactive prevention through enhanced clinical surveillance, early prediction and rational intervention, thereby preventing fibrosis progression and improving outcomes in ARDS survivors.
科研通智能强力驱动
Strongly Powered by AbleSci AI